Pharm
Aminoglycoside
search
Aminoglycoside
, Gentamicin, Garamycin
Pharmacokinetics
Maintain Trough <2 ug/ml
Drawn immediately before next dose
Maintain Peak at 5-8 ug/ml (4-6 ug/ml for child)
Draw 1 hour after Intramuscular dose
Indications for
Pharmacokinetics
followed by PharmD
Aminoglycoside use over 3 days
Renal dysfunction
Precautions
Administer IV dose over 1 hour
Adjust dosing per kinetics if >1-2 days use
Aminoglycosides are associated with risk of
Ototoxicity
and nephrotoxicity (FDA black box warning)
Dosing
Infants
Term Infant
Gentamycin 2.5 mg/kg/dose IV or IM q8 hours
Preterm Infant
Gestational age
>34 weeks and Weight over 2000 grams
Gentamycin 2.5 mg/kg/dose IV or IM q12 hours
Gestational age
<34 weeks
Weight over 1250 grams
Gentamycin 2.5 mg/kg/dose IV or IM q18 hours
Weight Under 1250 grams
Gentamycin 2.5 mg/kg/dose IV or IM q24 hours
Age >7 days
Gentamycin 2.5 mg/kg/dose IV or IM q12 hours
Renal
Impairment
Adjustments
Serum Creatinine
0.7 to 1.1
Gentamycin 2.5 mg/kg/dose IV or IM q24 hours
Serum Creatinine
1.1 to 1.3
Gentamycin 2.5 mg/kg/dose IV or IM q36 hours
Serum Creatinine
> 1.3
Gentamycin 2.5 mg/kg/dose IV or IM q48 hours
Dosing
Children and adults
Child
Gentamicin 2 to 2.5 mg/kg IV or IM q8 hours
Gentamicin 4.5 mg/kg IV q24 hours
Adults
Gentamicin 1-1.5 mg/kg IV or IM q8 hours or
Gentamicin 5-7 mg/kg IV q24 hours
Risk Factors for Nephrotoxicity
Advanced age
Prior
Renal Insufficiency
Dehydration
Hypokalemia
Hypomagnesemia
Liver
disease
Sepsis
Drug Interaction
s with other nephrotoxic medications
Cephalothin (Keflin) and other
Cephalosporin
s
Cyclosporin A
Cisplatin
NSAID
S
ACE Inhibitor
s
Methoxyflurane
Loop Diuretic
s
Amino Acid
s
Type your search phrase here